MicroRNA expression profiles in differentiated thyroid cancer, a review

被引：0
作者：
Li, Xinying [1 ,3 ]
Abdel-Mageed, Asim B. [2 ]
Mondal, Debasis [2 ]
Kandil, Emad [2 ]
机构：
[1] Tulane Univ, Sch Med, Dept Surg, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA
[3] Cent S Univ, Dept Gen Surg, Xianya Hosp, Changsha, Hunan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2013年 / 6卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Differentiated thyroid cancer; microRNA; mutations; fine needle aspiration biopsy; IN-VIVO; CARCINOMA; REARRANGEMENT; MIRNAS; TUMORS; TRANSCRIPTION; PROTEIN; SET;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
MicroRNAs (miRNAs) are a class of short endogenous non-coding RNAs regulating gene expression in many biological processes, including proliferation, apoptosis and differentiation. The deregulation of miRNA expression is believed to be an important regulator of tumor development and progression of thyroid cancer. In this review, we discussed important roles and expression profiles of miRNA in differentiated thyroid cancer (DTC) as well as the promising implication in clinical practice.
引用
收藏
页码：74 / 80
页数：7
相关论文
共 50 条
  • [21] MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls
    Yoruker, Ebru Esin
    Terzioglu, Duygu
    Teksoz, Serkan
    Uslu, Fatma Ezel
    Gezer, Ugur
    Dalay, Nejat
    JOURNAL OF CANCER, 2016, 7 (07): : 803 - 809
  • [22] Expression of the sodium iodide symporter in differentiated thyroid cancer
    Schmitz, G
    Füzesi, L
    Struck, J
    Siefker, U
    Hamann, A
    Sahlmann, CO
    Hüfner, M
    Meller, J
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (03): : 86 - 93
  • [23] Expression of YY1 in Differentiated Thyroid Cancer
    Jéssica Arribas
    Josep Castellví
    Ricard Marcos
    Carles Zafón
    Antonia Velázquez
    Endocrine Pathology, 2015, 26 : 111 - 118
  • [24] Reduced expression of FOXE1 in differentiated thyroid cancer, the contribution of CPG methylation, and their clinical relevance
    De Lima, Erika Urbano
    Dos Santos, Filipe Ferreira
    Da Silva, Igor Campos
    De Lima, Claudio Rogerio Alves
    Frutuoso, Vitoria Sousa
    Caso, Gustavo Felisola
    De Oliveira, Paloma Ramos
    Bezerra, Ana Karina
    Cerutti, Janete Maria
    Tamura, Rodrigo Esaki
    Ramos, Helton Estrela
    Rubio, Ileana Gabriela Sanchez de
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [25] Expression of GRIM-19 in differentiated thyroid cancer and its clinical significance
    Shen, Guohua
    Cai, Huawei
    Ma, Yu
    Zhao, Zhen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11): : 11781 - 11787
  • [26] PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
    Sollini, Martina
    di Tommaso, Luca
    Kirienko, Margarita
    Piombo, Chiara
    Erreni, Marco
    Lania, Andrea Gerardo
    Erba, Paola Anna
    Antunovic, Lidija
    Chiti, Arturo
    EJNMMI RESEARCH, 2019, 9 (01)
  • [27] Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
    Gomes-Lima, Cristiane J.
    Shobab, Leila
    Wu, Di
    Ylli, Dorina
    Bikas, Athanasios
    McCoy, Matthew
    Feldman, Rebecca
    Lee, Wen
    Rao, Sarika N.
    Jensen, Kirk
    Vasko, Vasily
    Castro, Luiz Claudio
    Jonklaas, Jacqueline
    Wartofsky, Leonard
    Burman, Kenneth D.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [28] Management of Thyroid Nodules and Surgery for Differentiated Thyroid Cancer
    Iyer, N. G.
    Shaha, A. R.
    CLINICAL ONCOLOGY, 2010, 22 (06) : 405 - 412
  • [29] Comprehensive annotation of microRNA expression profiles
    Sun, Bo
    Yang, Fei
    Hu, Fei-Hu
    Huang, Ning-Ping
    Xiao, Zhong-Dang
    BMC GENETICS, 2013, 14
  • [30] Deregulation of microRNA expression in thyroid tumors
    Yuan, Zi-ming
    Yang, Zhi-li
    Zheng, Qi
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2014, 15 (03): : 212 - 224
12345